| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.25 | 0.05 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |